Covered recipient · General Payments record
SARAH T BLACKSTOCK
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Critical Care Medicine
General Payments · PY2021–2024
$3,891.14
- Reported across 166 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $294.76 | 14 |
| Education | $13.20 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $92.77 | 5 |
| ABBVIE INC. | $50.16 | 2 |
| Shionogi Inc | $34.01 | 2 |
| BOSTON SCIENTIFIC CORPORATION | $29.41 | 1 |
| Amgen Inc. | $24.99 | 1 |
| Acerta Pharma LLC | $21.95 | 1 |
| Mallinckrodt Hospital Products Inc. | $19.82 | 1 |
| BAXTER HEALTHCARE | $19.12 | 1 |
| La Jolla Pharmaceutical Company | $15.73 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.63 | 04/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106768914 | CMS |
| ABBVIE INC. | $29.53 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106768919 | CMS |
| Amgen Inc. | $24.99 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117204483 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.95 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104781210 | CMS |
| Baxter Healthcare | $19.12 | 01/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120627773 | CMS |
| Boston Scientific Corporation | $29.41 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092389120 | CMS |
| GlaxoSmithKline, LLC. | $15.04 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116720194 | CMS |
| GlaxoSmithKline, LLC. | $15.21 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116289800 | CMS |
| GlaxoSmithKline, LLC. | $27.50 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116733858 | CMS |
| GlaxoSmithKline, LLC. | $14.96 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116699395 | CMS |
| GlaxoSmithKline, LLC. | $20.06 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115891615 | CMS |
| La Jolla Pharmaceutical Company | $15.73 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154252196 | CMS |
| Mallinckrodt Hospital Products Inc. | $19.82 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145160361 | CMS |
| Shionogi Inc | $20.81 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154342548 | CMS |
| Shionogi Inc | $13.20 | 08/01/2024 | Education | Undisputed | 01/23/2026 | 1154342624 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.